Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Pathogenetix, Inc. - Medical Equipment - Deals and Alliances Profile
Publication Date Jun 2012
Publisher GlobalData
Product Type Report
Pages 21
Single User License help $ 250.00
Site User License help $ 500.00
Corporate User License help $ 750.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Pathogenetix, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

Pathogenetix, Inc. (Pathogenetix) is a privately-held healthcare service company, based in the US. It develops and manufactures instruments and reagents for contract research organizations and biotech, pharmaceutical and academia companies. The company develops biological sensors for the detection and identification of pathogens and biomarkers in air, human serum, and other biological materials. It has initiated commercial applications of single molecule DNA, RNA and protein analysis and its innovative technologies address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring. Pathogenetix has established over 30 scientific collaborations with major academic and diagnostic research laboratories, biotech and pharmaceutical companies. Its product, the Trilogy platform, provides analysis and detection of RNA molecules, DNA molecules and proteins without amplification.The company is headquartered in Woburn, Massachusetts, the US.

Pathogenetix, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 4
Pathogenetix, Inc., Medical Equipment Deals By Type, 2006 to YTD 2012 5
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 6
Pathogenetix, Inc., Medical Equipment, Deals By Market, 2006 to YTD 2012 7
Pathogenetix, Inc., Medical Equipment, Deals Summary, 2006 to YTD 2012 8
Pathogenetix, Inc., Medical Equipment, Deal Details 9
Venture Financing 9
Pathogenetix Secures Additional $7.5 Million In Series B Financing 9
Pathogenetix Secures $1.51 Million In Venture Financing 11
U.S. Genomics Secures $1.31 Million In Venture Financing 12
U.S. Genomics Secures $1 Million In Venture Financing 13
Pathogenetix Secures $4.5 Million In Venture Financing 14
Partnerships 15
Pathogenetix Enters Into Co-Development Agreement With Sagentia 15
U.S. Genomics Enters Into Co-Development Agreement With Becton, Dickinson and Company 16
Rosetta Genomics Enters Into Collaboration With U.S Genomics 17
Pathogenetix, Inc. - Key Competitors 18
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
May 08, 2011: U.S. Genomics Appoints Salamone To Board 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
List of Tables
Pathogenetix, Inc., Medical Equipment, Key Facts 1
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 1
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 1
Pathogenetix, Inc., Medical Equipment, Deals By Market, 2006 to YTD 2012 1
Pathogenetix, Inc., Medical Equipment, Deals Summary, 2006 to YTD 2012 1
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 4
Pathogenetix, Inc., Medical Equipment Deals By Type, 2006 to YTD 2012 5
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 6
Pathogenetix, Inc., Deals By Market, 2006 to YTD 2012 7
Pathogenetix, Inc., Medical Equipment, Deals Summary, 2006 to YTD 2012 8
Pathogenetix Secures Additional $7.5 Million In Series B Financing 9
Pathogenetix Secures $1.51 Million In Venture Financing 11
U.S. Genomics Secures $1.31 Million In Venture Financing 12
U.S. Genomics Secures $1 Million In Venture Financing 13
Pathogenetix Secures $4.5 Million In Venture Financing 14
Pathogenetix Enters Into Co-Development Agreement With Sagentia 15
U.S. Genomics Enters Into Co-Development Agreement With Becton, Dickinson and Company 16
Rosetta Genomics Enters Into Collaboration With U.S Genomics 17
Pathogenetix, Inc., Key Competitors 18
Pathogenetix, Inc., Key Employees 18

List of Figures
List of Figures
Pathogenetix, Inc., Medical Equipment, Deals by Type, 2006 to YTD 2012 1
Pathogenetix, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 4
Pathogenetix, Inc., Medical Equipment, Deals by Type, 2006 to YTD 2012 5
Pathogenetix, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 6
Pathogenetix, Inc., Medical Equipment, Deals by Market, 2006 to YTD 2012 7

Title Date Price
2013 Deep Research Report on China Human Use Rabies Vaccine Industry
By QYResearch
2013 Deep Research Report on China Human Use Rabie Vaccine Industry is a professional and depth research report on China Human Use Rabies Vaccine industry. This report has firstly introduced Human Use ...Read More
Jan 2013 $2000.00
By Netscribes (India) Pvt. Ltd.
May 2012 $0.00
Abdominal Obesity-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abdominal Obesity-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establ ...Read More
$1250.00
Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abortion-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00
Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abscess-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00
Abscess-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abscess-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the un ...Read More
$1250.00
Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and m ...Read More
$2000.00
Absence Seizure-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   
   
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z